Table: Sawai Pharmaceutical - 9-MTH group results
Feb 13 (Reuters)-
Sawai Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2017 Dec 31, 2016 Mar 31, 2018
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 116.54 101.38
(+15.0 pct) (+9.7 pct)
Operating 19.10 17.90
(+6.7 pct) (-7.4 pct)
Recurring 19.67 17.87
(+10.1 pct) (-6.5 pct)
Net 14.04 13.69
(+2.6 pct) (-2.2 pct)
EPS 377.01 yen 371.35 yen
EPS Diluted 376.76 yen 371.13 yen
Ann Div 130.00 yen 130.00 yen
-Q2 div 65.00 yen 65.00 yen
-Q4 div 65.00 yen 65.00 yen
NOTE - Sawai Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4555.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on SAWAI group
See all newsTable: Sawai Group Holdings -Q1 group results (IFRS)
Table: Sawai Group Holdings -2025/26 group results (IFRS)
Brief: Silchester International Cuts Stake In Sawai Group Holdings To 5.82% From 6.83%, Regulatory Filing Shows
Table: Sawai Group Holdings -9-MTH group results (IFRS)
Table: Sawai Group Holdings 6-MTH group results (IFRS)